Mesa Laboratories Inc (MLAB) stock
Close on Nov 11, 2026Market cap $779.00MP/E 121.1Yield 0.46%
Mesa Laboratories Inc grew revenue 2.5% to $251.32M over the twelve months to Sep 30, 2026. Operating income rose 73.9% to $26.14M, moving the operating margin from 6.1% to 10.4%. Free cash flow was $49.45M, up 32.8% from a year earlier. At the latest close the market valued the company at $779.00M, 121.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $779.00M
- P/E ratio
- 121.1
- Price to sales
- 3.10
- Price to book
- 4.00
- Dividend yield
- 0.46%
- Free cash flow yield
- 6.35%
Fundamentals
- Revenue
- $251.32M
- Net income
- $6.67M
- EPS, diluted
- $1.15
- Free cash flow
- $49.45M
- Book value per share
- $33.78
- Diluted shares
- 6M
Trading
- Next earnings
- Feb 2, 2027 (estimated, before the open)
- Previous close
- $136.91
- Open
- $137.38
- Day's range
- $137.38 – $142.98
- Volume
- 183,742
- Average volume (20 days)
- 105,302
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.00
- 52-week range
- $69.51 – $144.35
- RSI (14 days)
- 61.8
- Volatility (1 year)
- 53.8%
- Relative volume
- 1.31×
- WACC
- 9.9%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MLAB | S&P 500 | Difference | MLAB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.2% | -2.4% | +11.6 pts | ||
| 3 months | +25.3% | -1.2% | +26.5 pts | ||
| Year to date | +78.1% | +12.3% | +65.8 pts | ||
| 1 year | +75.0% | +12.4% | +62.6 pts | ||
| 3 years | +66.8% | +78.8% | −12.0 pts | +18.6% | +21.4% |
| 5 years | -54.5% | +75.2% | −129.7 pts | -14.6% | +11.9% |
| 10 years | +16.7% | +311.1% | −294.4 pts | +1.6% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Mesa Laboratories filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
About Mesa Laboratories
Industrial Instruments For Measurement, Display, and Control
Mesa Laboratories, Inc. designs and manufactures life sciences tools and quality control solutions for regulated applications. The company operates through four primary divisions: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Its product offerings encompass biological and chemical indicators, genetic analysis instruments, automated systems for protein analysis and peptide synthesis, continuous monitoring systems, and calibration instruments. Mesa also provides maintenance, testing, and calibration services. It serves customers in the pharmaceutical, healthcare, medical device, dental, and academic sectors.
Company profile, executives and historyMesa Laboratories stock: common questions
What is Mesa Laboratories's stock price?
MLAB closed at $139.21 on Nov 11, 2026, up 1.68% on the day. Over the past 52 weeks it traded between $69.51 and $144.35.
What is Mesa Laboratories's market cap?
Mesa Laboratories was worth $779.00M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MLAB's P/E ratio?
MLAB trades at 121.1 times earnings, based on diluted earnings per share of $1.15 over the twelve months to Sep 30, 2026.
How much revenue does Mesa Laboratories make?
Mesa Laboratories reported revenue of $251.32M for the twelve months to Sep 30, 2026, up 2.5% from a year earlier.
Does Mesa Laboratories pay a dividend?
Yes. Mesa Laboratories paid $0.64 per share over the last twelve months, a yield of 0.46% at the latest price.
When does Mesa Laboratories report earnings next?
Mesa Laboratories is expected to report Q3 FY2027 results on Feb 2, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has MLAB stock performed over the past year?
Including dividends, MLAB returned +75.0% over the past year, against +12.4% for the S&P 500.
How many MLAB shares are sold short?
0M shares were sold short at the latest FINRA report, 6.99% of the float, or 4.7 days of average trading volume.
Who are Mesa Laboratories's competitors?
Companies most similar to Mesa Laboratories by business, industry and size include HURC, CTKB, SYPR, INTT, PACB.
See a number that looks wrong?